Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  White, Nicholas J ^a,b   Ashley, Elizabeth A ^a   Recht, Judith ^a   Delves, Michael J ^c   Ruecker, Andrea ^c   Smithuis, Frank M ^b,d   Eziefula, Alice C ^e   Bousema, Teun ^e   Drakeley, Chris ^e   Chotivanich, Kesinee ^a   Imwong, Mallika ^a   Pukrittayakamee, Sasithon ^a   Prachumsri, Jetsumon ^f   Chu, Cindy ^a   Andolina, Chiara ^a   Bancone, Germana ^a   Hien, Tran T ^g   Mayxay, Mayfong ^h   Taylor, Walter R J ^a   Von Seidlein, Lorenz ^a   Price, Ric N ^a,i   Barnes, Karen I ^j   Djimdé, Abdoulaye ^k   Kuile, Feiko Ter ^l   Gosling, Roly ^m   Chen, Ingrid ^m   Dhorda, Mehul J ^b,n   Stepniewska, Kasia ⁿ   Guérin, Philippe ⁿ   Woodrow, Charles J ^a,b   Dondorp, Arjen M ^a,b   Day, Nicholas P J ^a,b   Nosten, Francois H ^a,b   more..

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d Myanmar   (Myanmar)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f MAHIDOL UNIVERSITY   (Thailand)

^g OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^h MAHOSOT HOSPITAL   (Laos)

ⁱ MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^j UNIVERSITY OF CAPE TOWN   (South Africa)

^k UNIVERSITY OF BAMAKO   (Mali)

^l LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^m UCSF Global Health Sciences   (United States)

ⁿ CHURCHILL HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

8 AMINOQUINOLINE DERIVATIVE; ARTESUNATE; PLACEBO; PLASMOQUINE; PRIMAQUINE; TETRACYCLINE; UNCLASSIFIED DRUG; AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT;

ANTIPROTOZOAL ACTIVITY; APICOMPLEXAN LIFE CYCLE STAGE; AREA UNDER THE GAMETOCYTEMIA TIME CURVE; DRUG EFFICACY; DRUG SENSITIVITY; GAMETOCYTE (LIFE CYCLE STAGE); GAMETOCYTEMIA; GENERAL PATHOLOGICAL PARAMETERS; HOST PARASITE INTERACTION; HUMAN; LOW DRUG DOSE; MALARIA FALCIPARUM; NONHUMAN; PARASITE CLEARANCE; PARASITE EXAMINATION; PARASITE TRANSMISSION; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; SYSTEMATIC REVIEW (TOPIC); TREATMENT DURATION; TREATMENT RESPONSE; DISEASE TRANSMISSION; DRUG EFFECTS; MALARIA, FALCIPARUM; PARASITEMIA; PREVENTION AND CONTROL; TIME FACTOR; TRANSMISSION; TREATMENT OUTCOME;

AMINOQUINOLINES; ANTIMALARIALS; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; MALARIA, FALCIPARUM; PARASITEMIA; PLASMODIUM FALCIPARUM; TIME FACTORS; TREATMENT OUTCOME;

EID: 84926450796     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-483     Document Type: Review

References (64)

1. WHO: Guidelines for the Treatment of Malaria. 2nd edition. Geneva: World Health Organization; 2010.
2. Price R, Nosten F, Simpson JA, Luxemburger C, Phaipun L, ter Kuile F, van Vugt M, Chongsuphajaisiddhi T, White NJ: Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg 1999, 60:1019-1023.
3. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ: Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996, 347:1654-1658.
4. Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, White NJ: Activities of artesunate and primaquine against asexual-and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother 2004, 48:1329-1334.
5. Drakeley CJ, Jawara M, Targett GA, Walraven G, Obisike U, Coleman R, Pinder M, Sutherland CJ: Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Trop Med Int Health 2004, 9:53-61.
6. Chotivanich K, Sattabongkot J, Udomsangpetch R, Looareesuwan S, Day NP, Coleman RE, White NJ: Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob Agents Chemother 2006, 50:1927-1930.
7. El-Sayed B, El-Zaki SE, Babiker H, Gadalla N, Ageep T, Mansour F, Baraka O, Milligan P, Babiker A: A randomized open-label trial of artesunate-sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan. PLoS One 2007, 2:e1311.
8. Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T: Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One 2007, 2:e1023.
9. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ: Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J 2008, 7:125.
10. White NJ: Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis 2013, 13:175-181.
11. Ashley EA, Recht J, White NJ: Primaquine: the risks and the benefits. Malar J 2014, 13:418.
12. WHO: Single Dose Primaquine as a Gametocytocide in Plasmodium Falciparum Malaria; Updated WHO Policy Recommendation. Geneva: World Health Organization; 2012 [http://www.who.int/malaria/publications/atoz/who-pq-policy-recommendation/en/]
13. White NJ, Qiao LG, Qi G, Luzzatto L: Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar J 2012, 11:418.
14. Recht J, Ashley EA, White NJ: Safety of 8-aminoquinoline Antimalarial Medicines. Geneva: World Health Organization; 2014.
15. Graves PM, Gelband H, Garner P: Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission. Cochrane Database Syst Rev 2014, 6:CD008152.
16. Eziefula AC, Bousema T, Yeung S, Kamya M, Owaraganise A, Gabagaya G, Bradley J, Grignard L, Lanke KH, Wanzira H, Mpimbaza A, Nsobya S, White NJ, Webb EL, Staedke SG, Drakeley C: Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. Lancet Infect Dis 2014, 14:130-139.
17. Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, Naing AL, Nyo MY, Myint NZ, Imwong M, Ashley E, Lee SJ, White NJ: Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect Dis 2010, 10:673-681.
18. Bousema T, Drakeley C: Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev 2011, 24:377-410.
19. Smalley ME: Plasmodium falciparum gametocytes: the effect of chloroquine on their development. Trans R Soc Trop Med Hyg 1977, 71:526-529.
20. Sinden RE: Sexual development of malarial parasites. Adv Parasitol 1983, 22:153-216.
21. Thomson D: A research into the production, life and death of crescents in malignant tertian malaria, in treated and untreated cases, by an enumerative method. Ann Trop Med Parasitol 1911, 5:57-85.
22. Ciuca M, Ballif L, Chearescu M, Lavrinenko N: Contribution à l'étude de l'infection expérimentale au Plasmodium falciparum. Hamburg: Festchrift Institute Bernard Nocht; 1937:81-101.
23. Mair GR, Braks JAM, Garver LS, Wiegant JCAG, Hall N, Dirks RW, Khan SM, Dimopoulos G, Janse CJ, Waters AP: Regulation of sexual development of Plasmodium by translational repression. Science 2006, 313:667-669.
24. Robert V, Sokhna CS, Rogier C, Ariey F, Trape JF: Sex ratio of Plasmodium falciparum gametocytes in inhabitants of Dielmo, Senegal. Parasitology 2003, 127:1-8.
25. Talman AM, Domarle O, McKenzie FE, Ariey F, Robert V: Gametocytogenesis: the puberty of Plasmodium falciparum. Malar J 2004, 3:24.
26. Sowunmi A, Balogun ST, Gbotosho GO, Happi CT: Plasmodium falciparum gametocyte sex ratios in children with acute, symptomatic, uncomplicated infections treated with amodiaquine. Malar J 2008, 7:169.
27. Sowunmi A, Balogun ST, Gbotosho GO, Happi CT: Plasmodium falciparum gametocyte sex ratios in symptomatic children treated with antimalarial drugs. Acta Trop 2009, 109:108-117.
28. Kar PK, Dua YK, Gupta NC, Gupta A, Dash AP: Plasmodium falciparum gametocytaemia with chloroquine chemotherapy in persistent malaria in an endemic area of India. Indian J Med Res 2009, 129:299-304.
29. Sowunmi A, Gbotosho GO, Happi CT, Folarin OA, Balogun ST: Population structure of Plasmodium falciparum gametocyte sex ratios in malarious children in an endemic area. Parasitol Int 2009, 58:438-443.
30. Gbotosho GO, Sowunmi A, Happi CT, Okuboyejo TM: Plasmodium falciparum gametocyte carriage, sex ratios and asexual parasite rates in Nigerian children before and after a treatment protocol policy change instituting the use of artemisinin-based combination therapies. Mem Inst Oswaldo Cruz 2011, 106:685-690.
31. Gbotosho GO, Sowunmi A, Okuboyejo TM, Happi CT, Michael OS, Folarin OA, Adewoye EO: Plasmodium falciparum gametocyte carriage, emergence, clearance and population sex ratios in anaemic and non-anaemic malarious children. Mem Inst Oswaldo Cruz 2011, 106:562-569.
32. Delves MJ, Ruecker A, Straschil U, Lelièvre J, Marques S, López-Barragán MJ, Herreros E, Sinden RE: Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs. Antimicrob Agents Chemother 2013, 57:3268-3274.
33. Mollow W: Uber die gameten-zerstorende Wirkung des Plasmochins. Arch Schiffs TropenHyg 1928, 32:116-119.
34. Shute PG, Maryon M: A study of gametocytes in a West African strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg 1951, 44:421-438.
35. White NJ: The parasite clearance curve. Malar J 2011, 10:278.
36. Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, Sutherland C, Sauerwein R, Ghani AC, Drakeley C: Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J 2010, 9:136.
37. Babiker HA, Schneider P, Reece SE: Gametocytes: insights gained during a decade of molecular monitoring. Trends Parasitol 2008, 24:525-530.
38. Schneider P, Reece S, van Schaijk B, Meaden C, Ranford-Cartwright L, Gadalla A, Babiker H: Quantification of male and female Plasmodium falciparum gametocytes by real-time PCR. Mol Biol Parasitol 2014, in press.
39. Tao D, Ubaida-Mohien C, Mathias DK, King JG, Pastrana-Mena R, Tripathi A, Goldowitz I, Graham DR, Moss E, Marti M, Dinglasan RR: Sex-partitioning of the Plasmodium falciparum stage V gametocyte proteome provides insight into falciparum-specific cell biology. Mol Cell Proteomics 2014, 13:2705-2724.
40. Barnes KI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, Roper C, Watkins B, White NJ: Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. J Infect Dis 2008, 197:1605-1613.
41. Distiller GB, Little F, Barnes KI: Nonlinear mixed effects modeling of gametocyte carriage in patients with uncomplicated malaria. Malar J 2010, 9:60.
42. Stepniewska K, Price RN, Sutherland CJ, Drakeley CJ, von Seidlein L, Nosten F, White NJ: Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar J 2008, 7:249.
43. Jeffery GM, Eyles DE: Infectivity to mosquitoes of Plasmodium falciparum as related to gametocyte density and duration of infection. Am J Trop Med Hyg 1955, 4:781-789.
44. Churcher TS, Bousema T, Walker M, Drakeley C, Schneider P, Ouédraogo AL, Basáñez MG: Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection. E-life 2013, 2:e00626.
45. Shute PG, Maryon M: Laboratory Technique for the Study of Malaria. 2nd edition. London: J&A Churchill Ltd; 1966.
46. Bousema T, Dinglasan RR, Morlais I, Gouagna LC, van Warmerdam T, Awono-Ambene PH, Bonnet S, Diallo M, Coulibaly M, Tchuinkam T, Mulder B, Targett G, Drakeley C, Sutherland C, Robert V, Doumbo O, Touré Y, Graves PM, Roeffen W, Sauerwein R, Birkett A, Locke E, Morin M, Wu Y, Churcher TS: Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers. PLoS One 2012, 7:e42821.
47. Churcher TS, Blagborough AM, Delves M, Ramakrishnan C, Kapulu MC, Williams AR, Biswas S, Da DF, Cohuet A, Sinden RE: Measuring the blockade of malaria transmission-an analysis of the standard membrane feeding assay. Int J Parasitol 2012, 42:1037-1044.
48. Kone A, van de Vegte-Bolmer M, Siebelink-Stoter R, van Gemert GJ, Dara A, Niangaly H, Luty A, Doumbo OK, Sauerwein R, Djimde AA: Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival. Int J Parasitol 2010, 40:1221-1228.
49. Beavogui AH, Djimde AA, Gregson A, Toure AM, Dao A, Coulibaly B, Ouologuem D, Fofana B, Sacko A, Tekete M, Kone A, Niare O, Wele M, Plowe CV, Picot S, Doumbo OK: Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali. Int J Parasitol 2010, 40:1213-1220.
50. Ouedraogo AL, Bousema T, Schneider P, de Vlas SJ, Ilboudo-Sanogo E, Cuzin-Ouattara N, Nébié I, Roeffen W, Verhave JP, Luty AJ, Sauerwein R: Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. PLoS One 2009, 4:e8410.
51. Rosenberg R: Malaria: some considerations regarding parasite productivity. Trends Parasitol 2008, 24:487-491.
52. Rieckmann KH, McNamara JV, Frischer H, Stockert TA, Carson PE, Powell RD: Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. Bull World Health Organ 1968, 38:625-632
53. Young MD: The effect of small doses of primaquine upon malaria infections. Indian J Malariol 1959, 13:69-74.
54. Roehl W: Malariatherapie mit Plasmochin in Spanien. Arch Schiffs TropenHyg 1927, 31:48-58.
55. Barber MA, Komp WHW: The Viability of Gametocytes in the Blood of Plasmochin-Treated Patients, 16th Ann Rept Med Dept United Fruit Co.; 1927:60-62.
56. Barber MA, Komp WH, Newman BM: The effect of small doses of plasmochin on the viability of gametocytes of malaria as measured by mosquito infection experiments. Public Health Rep 1929, 44:1409-1420
57. Jerace F, Giovannola A: L'azzione sterlizzante della plasmochina sui gametociti di parassiti malarigenie sua importanza profilattica. Riv Malariol 1933, 12:457-477.
58. Manson-Bahr PH: Further observations on the effects of plasmochin and "plasmochin-compound" on the gametocytes of benign tertian and subtertian malaria. Lancet 1928, 214:25-26
59. MacKerras MJ, Ercole QN: Observations on the action of quinine, atebrin and plasmoquine on the gametocytes of Plasmodium falciparum. Trans R Soc Trop Med Hyg 1949, 42:455-463.
60. Edgecomb JH, Arnold J, Yount EH Jr, Alving AS, Eichelberger L, Jeffery GM, Eyles D, Young MD: Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report. J Natl Malar Soc 1950, 9:285-292
61. Rieckmann KH, McNamara JV, Kass L, Powell RD: Gametocytocidal and sporontocidal effects of primaquine upon two strains of Plasmodium falciparum. Mil Med 1969, 134:802-819.
62. Delves MJ, Ramakrishnan C, Blagborough AM, Leroy D, Wells TNC, Sinden RE: A high throughput assay for the identification of malarial transmission-blocking drugs and vaccines. Int J Parasitol 2012, 42:999-1006.
63. Ruecker A, Mathias DK, Straschil U, Churcher TS, Dinglasan RR, Leroy D, Sinden RE, Delves MJ: A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs. Antimicrob Agents Chemother 2014, 58:7292-7302.
64. Pybus BS, Marcsisin SR, Jin X, Deye G, Sousa JC, Li Q, Caridha D, Zeng Q, Reichard GA, Ockenhouse C, Bennett J, Walker LA, Ohrt C, Melendez V: The metabolism of primaquine to its active metabolite is dependent on CYP 2D6. Malar J 2013, 12:212.